Literature DB >> 25231595

Successful re-endothelialization of a perfusable biological vascularized matrix (BioVaM) for the generation of 3D artificial cardiac tissue.

Birgit Andrée1, Katharina Bela, Tibor Horvath, Marco Lux, Robert Ramm, Letizia Venturini, Anatol Ciubotaru, Robert Zweigerdt, Axel Haverich, Andres Hilfiker.   

Abstract

Generating cellularized 3D constructs with clinical relevant dimensions is challenged by nutrition supply. This is of utmost importance for cardiac tissue engineering, since cardiomyocytes are extremely sensitive to malnutrition and hypoxia in vitro and after implantation. To develop a perfusable myocardial patch, we have focused on seeding a decellularized biological vascularized matrix (BioVaM) with endothelial cells. BioVaM is produced by decellularization of porcine small intestinal segments with preserved arterial and venous pedicles, which can be connected to a perfusion system in vitro or the host vasculature in vivo. The BioVaM vessel bed was re-seeded with porcine primary endothelial cells (pCEC). Seeding efficiency was influenced by detergent composition used for decellularization (sodium dodecyl sulfate (SDS) and/or Triton X-100) and the medium composition used for re-seeding. After decellularization, residual SDS was detected in the matrix affecting the survival of pCEC which showed a low tolerance to SDS and Triton X-100. Sensitivity to detergents was attenuated by supplementation of the medium with bovine serum albumin (BSA) or fetal calf serum (FCS). Pre-conditioning of the BioVaM with 20% FCS was not sufficient to attain pCEC survival in the vascular bed. However, re-cellularization was achieved by prolonged FCS supplementation during cultivation, resulting in a perfusable, re-endothelialized matrix of 11 cm2 in size. This achievement represents a promising step towards engineering of perfusable, 3D cardiac constructs with clinically relevant dimensions.

Entities:  

Mesh:

Year:  2014        PMID: 25231595     DOI: 10.1007/s00395-014-0441-x

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  6 in total

1.  A High-Efficiency Method for the Production of Endothelial Cells from Human Induced Pluripotent Stem Cells.

Authors:  Maryna Pavlova; Shennea S McGarvey; Ganna Bilousova; Igor Kogut
Journal:  Methods Mol Biol       Date:  2022

2.  Differentiation of Human Pluripotent Stem Cells into Functional Endothelial Cells in Scalable Suspension Culture.

Authors:  Ruth Olmer; Lena Engels; Abdulai Usman; Sandra Menke; Muhammad Nasir Hayat Malik; Frank Pessler; Gudrun Göhring; Dorothee Bornhorst; Svenja Bolten; Salim Abdelilah-Seyfried; Thomas Scheper; Henning Kempf; Robert Zweigerdt; Ulrich Martin
Journal:  Stem Cell Reports       Date:  2018-04-19       Impact factor: 7.765

Review 3.  Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart Disease.

Authors:  Alexis Bosman; Michael J Edel; Gillian Blue; Rodney J Dilley; Richard P Harvey; David S Winlaw
Journal:  J Clin Med       Date:  2015-04-22       Impact factor: 4.241

4.  Inadequate Processing of Decellularized Dermal Matrix Reduces Cell Viability In Vitro and Increases Apoptosis and Acute Inflammation In Vivo.

Authors:  Aaron H Morris; Julie Chang; Themis R Kyriakides
Journal:  Biores Open Access       Date:  2016-07-01

5.  Viability and proliferation of endothelial cells upon exposure to GaN nanoparticles.

Authors:  Tudor Braniste; Ion Tiginyanu; Tibor Horvath; Simion Raevschi; Serghei Cebotari; Marco Lux; Axel Haverich; Andres Hilfiker
Journal:  Beilstein J Nanotechnol       Date:  2016-09-23       Impact factor: 3.649

6.  Evaluation of a Miniaturized Biologically Vascularized Scaffold in vitro and in vivo.

Authors:  Sebastian Kress; Johannes Baur; Christoph Otto; Natalie Burkard; Joris Braspenning; Heike Walles; Joachim Nickel; Marco Metzger
Journal:  Sci Rep       Date:  2018-03-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.